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UMaine Medicine Internal Grant Program: 2020 Update 
Executive Summary 
Vice President for Research and Dean of the Graduate School, Kody Varahramyan, launched 
the​ ​UMaine Medicine Initiative​ in November 2018. As part of the launch, internal funding 
programs were created and the inaugural round of the internal grant programs yielded 12 
applications for funding. After a review panel process, a total of six awards were made, 
comprising: four seed grants, one infrastructure grant, and one NIH proposal development 
incentive award. Office of Research Development Director, Jason Charland, manages the 
UMaine Medicine grant program. Activity on these 12-month projects commenced in April 2019 
and no cost extensions have been granted through Fall 2020 due to COVID-19 operating 
conditions. The no cost extensions will enable the research teams to complete deliverables and 
submit follow-on funding applications over the next several months. The following report 
provides updates on research highlights, student research engagement, and follow-on external 
funding success that the internal grant dollars have been able to stimulate.  
  
To date, the initial investment of ​$309,769​ has resulted in: 
 
● $1,129,846 in follow-on external grant funding ​awarded to UMaine Medicine Internal 
Grant PIs, resulting in a ​2.65:1​ return on investment 
● 21 presentations​ given domestically and internationally (including in Canada, the United 
Kingdom, and Italy) 
● 8 publications​ related to research from the funded UMaine Medicine grant projects 
● 26 undergraduate and 13 graduate students​ participating in research and/or 
supported by grant funds 
Muscle and Healthspan Research Collaborative 
PI:​ Clarissa Henry (Molecular & Biomedical Sciences) 
 
Co-PIs:​ Ben King (Molecular & Biomedical Sciences), Sam Hess (Physics and 
Astronomy), Josh Kelley (Molecular & Biomedical Sciences) 
  
Research Focus Area:​ Immune System 
  
Abstract: ​This project is centered on the discovery of mechanisms that underlie 
skeletal muscle plasticity and health, using the zebrafish model. The research on 
skeletal muscle is important because skeletal muscle quality predicts immune system 




● The Kelley/Henry labs have collaborated to generate a data set that was used to 
drive machine learning of healthy versus unhealthy muscle. This image analysis 
is invaluable for the Henry lab and will be used in many future projects. 
● The Hess/Henry labs generated the appropriate constructs, injected them into 
zebrafish, and recently managed to get the first super-resolution image of the 
myotendinous junction in zebrafish. 
● Dr. Henry has been awarded two grants from NIH as follow-on funds from this 
project: $321,200 (renewable annually for four years) for a grant entitled 
Mechanisms of NAD+ action during muscle development and homeostasis​ and 
$431,586 for ​Neuromuscular development in a zebrafish dystroglycanopathy 
model.  
Mast Cell and Mitochondrial Disruption by Triclosan and Related Antimicrobials 
PI:​ Julie Gosse (Molecular & Biomedical 
Sciences) 
 
Co-PIs:​ Robert Gundersen (Molecular & 
Biomedical Sciences), Samuel Hess 
(Physics & Astronomy) 
 
Research Focus Area:​ Immune System 
  
Abstract: ​Triclosan (TCS) is an antimicrobial banned by the USDA from soaps, but still 
used in other products such as toothpaste. Dr. Gosse has previously discovered that 
TCS inhibits the function of mitochondria and immune cell type mast cells. In this 
project, the investigators studied the effects of TCS and TCS substitutes on plasma 
membrane potential, mast cell function, mitochondria and various cell types. This also 
helped to generate data for a competitive NIH grant application. 
  
Key updates: 
● This team includes nine graduate students and nine undergraduate students who 
are gaining significant training in lab work, and using this experience as the basis 
of their capstones and theses. 
● Dr. Gosse’s students have received a total of seven awards (altogether $23,360) 
to support their work on this project, including an INBRE Functional Genomics 
Thesis Fellowship ($3,500), an INBRE/Honors College Comparative Functional 
Genomics Junior Year Research Award ($1,400), an INBRE Summer Research 
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Fellowship ($9,660), a Frederick Radke Undergraduate Research Fellowship 
($500), and a 2019 Barry Goldwater Scholarship ($7,500). 
● Dr. Hess submitted an NIH R15 AREA proposal that is currently pending a 
funding decision.  
● The team has been studying and collecting data on CPC (cetyl pyridinium 
chloride, a chemical used in oral care products). They are working on a 
manuscript on CPC for peer review as they prepare an additional NIH R15 AREA 
proposal to be submitted in June 2020. 
Design and in vivo Testing of an Additively Manufactured, Percutaneous Surgical 
Implant that is Modified to Incorporate Negative Pressure Wound Therapy 
PI:​ James Weber (School of Food and Agriculture) 
 
Co-PIs:​ Kristy Townsend (School of Biology and Ecology), Anne Lichtenwalner 
(Cooperative Extension / School of Food and Agriculture), David Neivandt (Chemical 
and Biological Engineering), Ian Dickey, MD (Orthopedic Surgeon) 
  
Research Focus Area:​ Diagnostic Medicine 
  
Abstract: ​The long-term goal of this project was to develop medical implants that 
reduce the likelihood of post-surgical infection. Similar technology has been shown to 
reduce the rate of infection after surgery. This was an advancement of these 




● The team has completed the first round of swine surgeries and post-surgical 
recovery periods. Preliminary results show enhanced wound healing into their 
trans-cutaneous implants when they were under constant negative pressure from 
the vacuum-assisted wound therapy devices. 
● Dr. Weber established new collaborations with Acelity, Inc. (subsidiary of 3M 
Corporation), a manufacturer of vacuum-assisted wound management devices, 
that has led to the in-kind donation of 16 wound management devices for use by 




Role of Anthocyanin and Phenolic Acid Extracts from Wild Blueberries on Wound 
Healing as related to Diabetes, Ischemic conditions and Tissue Regeneration 
PI:​ Dorothy Klimis-Zacas (School of Food and Agriculture) 
 
Co-PIs:​ Kristy Townsend (School of Biology 
and Ecology), James Weber (School of Food 
and Agriculture) 
  
Research Focus Area:​ Immune System 
 
Abstract: ​The Klimis-Zacas lab has 
documented in vitro that a chemical 
compound extracted from Maine wild 
blueberries increased the speed of wound 
closure by 38 percent above the control. The purpose of this project was to validate 
those results and design a patch or spray prototype to be tested on humans, in order to 




● Dr. Klimis-Zacas has been in the press several times about this project (links 
below): 
○ UMaine Research News, March 4​th​, 2019 
○ Channel 5 WABI, January 27​th​, 2020 
○ WMTW 8 ABC, January 28​th​, 2020 
○ CBSN Boston, January 28​th​, 2020 
○ Mainebiz, January 29​th​, 2020 
● The project funded doctoral student Natalie VandenAkker who helped the team 
complete pre-clinical studies and is presently analyzing these data. Preliminary 
results show significant increases in wound closure in the experimental groups 
compared to the control. 
● The team has received follow-on funding from a variety of sources: $25,000 from 
MTI, $30,000 from an RRF Accelerator Grant (MIRTA), $25,000 from the Wild 
Blueberry Association of North America, and $5,000 from NSF I-Corps. 
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UMaine Medicine Infrastructure Grant Award: Leveraging the Power of Diffuse 
Optical Imaging 
PI:​ Karissa Tilbury (Chemical and Biomedical Engineering) 
 
Co-PIs:​ Andre Khalil (Chemical and Biomedical Engineering), Kristy Townsend (School 
of Biology and Ecology) 
  
Research Focus Area:​ Diagnostic Medicine 
  
Abstract: ​This infrastructure grant requested the acquisition of Reflect RS, a 
vendor-provided diffuse optical imaging system. Diffuse optical imaging allows for a 
safer, non-invasive means to study tissue-level alterations in metabolism. This 
instrumentation is intended for the study of tissue composition. The research team has 
made it available to other researchers within and beyond the university, as well as for 
work in future NIH and NSF grant proposals. 
  
Key updates: 
● Dr. Tilbury has presented on this project seven times in locations in Maine as 
well as Boston, MA, and Colombia, SC. Two presentations were led by Wyatt 
Austin, the M.S. student in her lab. 
● The Reflect RS from Modulim arrived in Fall 2019. The students of the Tilbury 
Lab have created a user-friendly set of instructions to complement the operating 
manual. 
● The team is developing analysis routines that are flexible and shareable with 
other investigators on campus. 
NIH Proposal Incentive Program Award: Diagnosing Breast Cancer through 
Biophysical Disruptions of Tissue Microenvironment 
PI:​ Andre Khalil (Biomedical Engineering) 
 
Collaborator(s):​ 1) Dr. Amy Harrow, MD, Radiologist, Section head, Women's Center, 
Eastern Maine Medical Center and 2) Dr. Ivette Emery, PhD, Translational Scientist and 
Catalyst, Maine Medical Center Research Institute 
  
Research Focus Area:​ Diagnostic Medicine 
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Abstract: ​The purpose of this award was to support a graduate student to assist the 
team in generating preliminary data for a grant submission to NIH via the Academic 
Research Enhancement Award (AREA – R15) program. 
  
Key updates: 
● Jeremy Juybari, a Master’s student in Mathematics, was supported by funds from 
this project has been accepted to a UMaine PhD program and plans to continue 
working with Dr. Khalil. 
● T​he team received a high score on an R15 proposal submitted in February 2019, 
but it was two points away from making the funding cut. With help from the 
graduate student last summer as well as working with the NIH program officer, 
the team improved and re-submitted the proposal. They expect to hear back with 
confirmation of funding from NIH in May 2020. 
● Dr. Khalil recently received a $500 travel award from the Office of the Vice 
President of Research and Dean of the Graduate School in order to meet the 
Program Officer of the NIH R15 program to which the team is submitting. This 
will also contribute to Dr. Khalil’s goal of eventually submitting an NIH R01 
proposal. 
Conclusion 
This inaugural round of UMaine Medicine seed funding has allowed researchers to 
showcase the university’s research expertise in the biomedical and health sciences as 
well as to highlight the potential for continued growth in this area. The external 
collaborations formed and the equipment acquired will likely contribute to future 
projects, and the $1.16 million in follow-on grant funding has expanded the scope of 
researchers’ plans. The direct impact of these investments will continue to accrue over 
the next several years. In addition, the 39 students who worked within these teams have 
received invaluable and unique experiences that will serve them throughout their 
educational and professional careers. 
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